Prulifloxacin
-
Prulifloxacin
structure -
-
CAS No:
123447-62-1
-
Formula:
C21H20FN3O6S
-
Chemical Name:
Prulifloxacin
-
Synonyms:
1H,4H-[1,3]Thiazeto[3,2-a]quinoline-3-carboxylic acid,6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-;1,3-Dioxole,1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid deriv.;6-Fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid;NM 441;(±)-7-[4-[(Z)-2,3-Dihydroxy-2-butenyl]-1-piperazinyl]-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid,cyclic carbonate;Prulifloxacin;Quisnon;Sword
-
Categories:
Active Pharmaceutical Ingredients > Synthetic Anti-infective Drugs
-
CAS No:
Description
Off-White SolidPrulifloxacin was launched as the third fluoroquinone. It was introduced in Japan as an oral treatment for urinary tract infections (UTls), respiratory tract infections (RTls) and bacterial pneumoniae. It can be synthesized in 10 steps from commercially available 3,4-difluoroaniline. Key steps involve the cyclization of 6,7-difluoro-rl-hydroxy-2- thioquinoline-3carboxylic acid ethyl ester with 1 ,I-dibromomethane to give the corresponding thiazeto-[3,2a]quinoline. Aromatic n
Prulifloxacin is a quinolone antibiotic and a fluoroquinolone antibiotic.|Prulifloxacin has been investigated for the treatment of Urinary Tract Infection.
Prulifloxacin Basic Attributes
461.46
461.46
1592732-453-0
DTXSID0046480
J - Antiinfectives for systemic use
Characteristics
125
1
Yellow or slightly yellow power
1.62±0.1 g/cm3(Predicted)
211-214°C
633.2±65.0 °C(Predicted)
336.8±34.3 °C
1.721
1 M NaOH: soluble25ML, clear, colorless (Solvent: 1 mg + 25 mL of NaOH)
-20°C Freezer
1.77E-20mmHg at 25°C
Safety Information
XJ0600000
P201, P260, P263, P264, P270, P308+P313, P314, P501
H362
|Warning|H362 (100%): May cause harm to breast-fed children [Reproductive toxicity, effects on or via lactation]|P201, P260, P263, P264, P270, P308+P313, P314, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Drug Information
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)|Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
6-fluoro-1-methyl-7-(4-(5-methyl-2-oxo-1,3-dioxelen-4-yl)methyl-1-piperazinyl)-4-oxo-4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid
Prulifloxacin Use and Manufacturing
the reaction vessel in step (3) obtained in prulifloxacin crude acetonitrile and 358L stirred heated to reflux to dissolve transparent, coolish, adding 0. 05kg charcoal, keep stirring under reflux for 30 minutes, filtered hot and the filtrate was natural cooled to room temperature and crystallization, through chilled water cooling crystallization overnight, centrifugation, washing the filter cake with a small amount of acetonitrile frozen crystal, drying, 80 ° C and dried under vacuum to dryness to give prulifloxacin finished 8. 73kg, yield (mole ) 92.4percent, purity 99.5percent 7. 0kg adding the compound of formula (III) in a reaction vessel, 2. 31kg potassium bicarbonate and 42L N, N- dimethylformamide, cooling down to 4 ° C, was added dropwise at a concentration of 0. 6kg / L of formula ( V) DMF solution of compound 12. 3L, controlling the internal temperature 4 ° C, dropwise Bi, 4 ° C with stirring, and the reaction time was 5.5 hours, the reaction solution was poured into ice water with stirring, and stirred for 0.5 hours, the crystals were collected by filtration, the filter cake washed with water until neutral, drained, 60~70 ° C hot air circulation drying, a compound of formula (I) prulifloxacin crude 9. 34kg, yield (moles) 96.8 percent, purity 92.6percent; (4) was added to the reaction vessel in step (3) obtained in prulifloxacin crude acetonitrile and 358L stirred heated to reflux to dissolve transparent, coolish, adding 0. 05kg activated carbon, insulation was stirred at reflux for 30 minutes, filtered hot and the filtrate cooled to room temperature crystallization, crystallization through the chilled water cooling overnight, centrifugation, washing the filter cake with a small amount of acetonitrile frozen crystal, drying, 80 ° C under vacuum to dryness to give Cape Lu Lisha star finished 8. 94kg, yield (mol) of 95.4percent, a purity of 99.7percentthe reaction vessel in step (3) obtained in prulifloxacin crude acetonitrile and 358L stirred heated to reflux to dissolve transparent, coolish, adding 0. 05kg charcoal, keep stirring under reflux for 30 minutes, filtered hot and the filtrate was natural cooled to room temperature and crystallization, through chilled water cooling crystallization overnight, centrifugation, washing the filter cake with a small amount of acetonitrile frozen crystal, drying, 80 ° C and dried under vacuum to dryness to give prulifloxacin finished 8. 73kg, yield (mole ) 92.4percent, purity 99.5percent 7. 0kg adding the compound of formula (III) in a reaction vessel, 2. 31kg potassium bicarbonate and 42L N, N- dimethylformamide, cooling down to 4 ° C, was added dropwise at a concentration of 0. 6kg / L of formula ( V) DMF solution of compound 12. 3L, controlling the internal temperature 4 ° C, dropwise Bi, 4 ° C with stirring, and the reaction time was 5.5 hours, the reaction solution was poured into ice water with stirring, and stirred for 0.5 hours, the crystals were collected by filtration, the filter cake washed with water until neutral, drained, 60~70 ° C hot air circulation drying, a compound of formula (I) prulifloxacin crude 9. 34kg, yield (moles) 96.8 percent, purity 92.6percent; (4) was added to the reaction vessel in step (3) obtained in prulifloxacin crude acetonitrile and 358L stirred heated to reflux to dissolve transparent, coolish, adding 0. 05kg activated carbon, insulation was stirred at reflux for 30 minutes, filtered hot and the filtrate cooled to room temperature crystallization, crystallization through the chilled water cooling overnight, centrifugation, washing the filter cake with a small amount of acetonitrile frozen crystal, drying, 80 ° C under vacuum to dryness to give Cape Lu Lisha star finished 8. 94kg, yield (mol) of 95.4percent, a purity of 99.7percent
Fluoroquinoline antibacterial; prodrug for active metabolite, Ulifloxacin. Antibacterial.
Computed Properties
Molecular Weight:461.5
XLogP3:1
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:4
Exact Mass:461.10568470
Monoisotopic Mass:461.10568470
Topological Polar Surface Area:125
Heavy Atom Count:32
Complexity:931
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
The drug targets bacterial DNA and inhibits the function of DNA topoisomerase II and IV, preventing bacterial DNA from forming supercoils and causing irreversible damage to chromosomes, which results in bacterial cells being unable to divide and reproduce, thus producing an antibacterial effect. This effect is generally highly selective for bacteria and safe for the human body.
Registered Holders
-
JUZEN CHEMICAL CORP
Active
United States
-
Zhejiang Warrant Pharmaceutical Co., Ltd.
Active
China
-
Hunan Warrant Chiral Pharmaceutical Co., Ltd.
Active
China
Recommended Suppliers of Prulifloxacin
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP -
CN
3 YRS
Business licensedTrader Supplier of Estradiol,Progesterone,GS441524,4-Butylresorcinol,DeoxyArbutin,Coenzyme Q10,Piracetam,Pregabalin,Ketoprofen,omeprazole,Fullerene C60,Melatonin,Nicotinamide riboside chloride,lactoferrin,Tylosin tartrate,Gentamycin Sulfate,Levamisole HCl,Praziquantel,Ivermectin,GA3,Pepsin,MT2,5 amino 1MQ,selank,semaxInquiryCAS No.: 123447-62-1Grade: Pharmaceutical GradeContent: 99% -
CN
3 YRS
Business licensedTrader Supplier of api,Intermediates,Organic Chemistry,Inorganic Chemistry,Daily Chemicals,Cosmetic Raw Materals,CATALYST AND AUXILIARY,FLAVORS AND FRAGRANCES,Chemical Pesticides,ADDITIVEInquiryCAS No.: 123447-62-1Grade: Pharmaceutical GradeContent: 99% -
CN
2 YRS
Business licensedTrader Supplier of API,Antibiotics,Anti cancer categoryInquiryUnit Price: $50 /MT EXWCAS No.: 123447-62-1Grade: Pharmaceutical GradeContent: 99% -
CN
1 YR
Business licensedTrader Supplier of Pharmaceutical intermediate/API, and fragrances APIInquiryCAS No.: 123447-62-1Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
Phenoxyethanol
122-99-6
-
4-Aminosalicylic acid
65-49-6
-
1,3-Propanediol, 2-[(acetyloxy)methoxy]-, 1,3-diacetate
86357-13-3
-
Ethanol, 2-[(acetyloxy)methoxy]-, 1-acetate Formula
59278-00-1
-
Maraviroc Formula
376348-65-1
-
Lopinavir Formula
192725-17-0
-
Luliconazole Structure
187164-19-8
-
Methenamine hippurate Structure
5714-73-8
-
What is Nifuratel
4936-47-4
-
What is Flumequine
42835-25-6